Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 333 followers

Latest posts

Last updated about 19 hours ago

Human medicines European public assessment report (EPAR): Kigabeq, vigabatrin, Date of authorisation: 20/09/2018, Revision: 9, Status: Authorised

about 19 hours ago

Human medicines European public assessment report (EPAR): Kigabeq, vigabatrin, Date of authorisation...

Lumykras : EPAR - Risk management plan

about 19 hours ago

Lumykras : EPAR - Risk management plan

Human medicines European public assessment report (EPAR): Orkambi, lumacaftor,ivacaftor, Date of authorisation: 19/11/2015, Revision: 39, Status: Authorised

about 20 hours ago

Human medicines European public assessment report (EPAR): Orkambi, lumacaftor,ivacaftor, Date of authorisation...

Human medicines European public assessment report (EPAR): Opzelura, ruxolitinib, Date of authorisation: 19/04/2023, Revision: 7, Status: Authorised

about 20 hours ago

Human medicines European public assessment report (EPAR): Opzelura, ruxolitinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Ryjunea, atropine sulfate, Date of authorisation: 02/06/2025, Revision: 1, Status: Authorised

about 21 hours ago

Human medicines European public assessment report (EPAR): Ryjunea, atropine sulfate, Date of...

Human medicines European public assessment report (EPAR): Voriconazole Accord, voriconazole, Date of authorisation: 16/05/2013, Revision: 23, Status: Authorised

about 21 hours ago

Human medicines European public assessment report (EPAR): Voriconazole Accord, voriconazole, Date of...

Academia

about 21 hours ago

Academia

Human medicines European public assessment report (EPAR): Lumykras, sotorasib, Date of authorisation: 06/01/2022, Revision: 7, Status: Authorised

about 22 hours ago

Human medicines European public assessment report (EPAR): Lumykras, sotorasib, Date of authorisation...

Human medicines European public assessment report (EPAR): Plerixafor Accord, plerixafor, Date of authorisation: 16/12/2022, Revision: 3, Status: Authorised

about 22 hours ago

Human medicines European public assessment report (EPAR): Plerixafor Accord, plerixafor, Date of...

Human medicines European public assessment report (EPAR): Zeffix, lamivudine, Date of authorisation: 29/07/1999, Revision: 32, Status: Authorised

about 23 hours ago

Human medicines European public assessment report (EPAR): Zeffix, lamivudine, Date of authorisation...

Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 5, Status: Authorised

about 23 hours ago

Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate...

Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 28, Status: Authorised

about 23 hours ago

Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation...